Compare China Isotope & Radiation Corp. with Similar Stocks
Dashboard
1
High Management Efficiency with a high ROE of 15.85%
2
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 22.66
3
Negative results in Dec 25
4
With ROE of 17.73%, it has a Attractive valuation with a 1.20 Price to Book Value
5
Market Beating Performance
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
49.34%
0%
49.34%
6 Months
67.94%
0%
67.94%
1 Year
68.88%
0%
68.88%
2 Years
13.51%
0%
13.51%
3 Years
3.14%
0%
3.14%
4 Years
-41.33%
0%
-41.33%
5 Years
-14.76%
0%
-14.76%
China Isotope & Radiation Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
14.03%
EBIT Growth (5y)
16.25%
EBIT to Interest (avg)
22.66
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.02
Sales to Capital Employed (avg)
1.04
Tax Ratio
15.96%
Dividend Payout Ratio
31.47%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
26.24%
ROE (avg)
15.85%
Valuation key factors
Factor
Value
P/E Ratio
7
Industry P/E
Price to Book Value
1.20
EV to EBIT
6.28
EV to EBITDA
5.05
EV to Capital Employed
1.19
EV to Sales
0.85
PEG Ratio
0.48
Dividend Yield
1.63%
ROCE (Latest)
18.94%
ROE (Latest)
17.73%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
7,795.20
8,212.70
-5.08%
Operating Profit (PBDIT) excl Other Income
1,301.70
1,352.20
-3.73%
Interest
69.70
44.80
55.58%
Exceptional Items
-0.20
0.20
-200.00%
Consolidate Net Profit
720.70
953.60
-24.42%
Operating Profit Margin (Excl OI)
130.90%
132.40%
-0.15%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -5.08% vs 12.02% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -24.42% vs 11.19% in Dec 2024
About China Isotope & Radiation Corp. 
China Isotope & Radiation Corp.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






